Ledger.Open graph →
SEC Form D · Amendment · filed August 13, 2020

Werewolf Therapeutics, Inc

Offering
$56.2M
Sold
$56.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Luke Evnin · Cambridge, MADirectorAlon Lazarus · Cambridge, MADirectorSakae Asanuma · Cambridge, MADirectorBriggs Morrison · Cambridge, MADirectorDaniel Hicklin · Cambridge, MAExec · DirectorDavid Cordo · Cambridge, MAExecChristoph Westphal · Boston, MADirectorDale R. Whipple · Nashua, NHDirectorKyle Sale · Boise, IDDirectorMarc R. Burel · Perkasie, PADirectorDavid Cordo · Cambridge, MAExecArthur Dzaghgouni · Grand Cayman, Cayman IslandsExec · DirectorDrew Eldred · Boise, IDDirectorRandal R. Betz · Bradenton, FLDirectorMicah Johnson · Boise, IDExecPete Hartigan · San Francisco, CAExec · DirectorDavid R. Mchale · Wilton, CTDirectorMatthew J. Arciuolo · Wilton, CTDirectorRalph Woodford · Grand Cayman, Cayman IslandsDirectorWhitney Haring-Smith · Tampra, FLDirectorBTG Pactual Consumer Asset Backed Investment GP, Ltd · Grand Cayman, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗